Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
koalafish完成签到,获得积分10
1秒前
科研通AI6.3应助yz123采纳,获得10
3秒前
3秒前
曾经尔云关注了科研通微信公众号
4秒前
脑洞疼应助端庄洋葱采纳,获得10
4秒前
李爱国应助酷炫小馒头采纳,获得10
5秒前
334w完成签到,获得积分20
6秒前
岳岳岳完成签到,获得积分10
6秒前
6秒前
星辰大海应助xy采纳,获得10
6秒前
8秒前
吖咪h完成签到 ,获得积分10
8秒前
nian完成签到,获得积分10
10秒前
AMENG发布了新的文献求助10
10秒前
依依完成签到 ,获得积分10
11秒前
我是老大应助款款采纳,获得10
12秒前
上官若男应助甜甜青旋采纳,获得10
12秒前
小二郎应助蓝天采纳,获得10
12秒前
13秒前
13秒前
xy发布了新的文献求助10
14秒前
星辰大海应助Aimeee采纳,获得10
14秒前
15秒前
16秒前
墨瞳完成签到,获得积分10
17秒前
18秒前
GXL发布了新的文献求助10
19秒前
jin完成签到,获得积分10
19秒前
蓝天发布了新的文献求助10
20秒前
武雨寒发布了新的文献求助10
21秒前
gaoyue高月完成签到,获得积分10
22秒前
鸡蛋发布了新的文献求助10
23秒前
研友_VZG7GZ应助孙皮皮采纳,获得10
23秒前
334w关注了科研通微信公众号
23秒前
大个应助weilanhaian采纳,获得10
24秒前
25秒前
26秒前
27秒前
希望天下0贩的0应助呜呜采纳,获得10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Applied Min-Max Approach to Missile Guidance and Control 3000
Metallurgy at high pressures and high temperatures 2000
Inorganic Chemistry Eighth Edition 1200
High Pressures-Temperatures Apparatus 1000
Free parameter models in liquid scintillation counting 1000
Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens, 7th edition 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6318359
求助须知:如何正确求助?哪些是违规求助? 8134625
关于积分的说明 17052670
捐赠科研通 5373307
什么是DOI,文献DOI怎么找? 2852250
邀请新用户注册赠送积分活动 1830165
关于科研通互助平台的介绍 1681813